We know what’s coming and we are prepared.
Fani Willis has a room temperature IQ.
She makes $110,000 a year.
And yet, she is worth $8 million.
In court, she admitted to several finance-related felonies.
The DOJ could take her down in a day if they wanted to….
Fani Willis wealth includes $2 million
in stock market investments. She
holds shares in Apple, Microsoft, Boeing, Berkshire Hathaway, Exxon and Pfizer. Additionally, Willis owns $600,000 in gold reserves and $275,000 in other bank deposits.
Breaking down her finances, Willis earns an annual income of $2.7 million, with a base salary of $110,000 and an additional $1.5 million from various sources, including a speaking fee of $12,000 per event. She owns eight cars.
Beyond the numbers, Willis's wealth includes $5 million in real estate, encompassing 300 acres of farmland in Utah and Maui, a 4-bedroom luxury villa in Georgia, and two properties in Houston.
Meanwhile, here’s Don Jr. worshipping at the feet of another demon god in India.
Follow @zeeemedia
Website | X | Instagram | Rumble
The village of Piddington has voted for independence from the United Kingdom and to become a self governing village in a landslide vote.
91% Voting Leave
This comes after news that over 3,000 illegal migrants are to be dumped in their village.
Follow @zeeemedia
Website | X | Instagram | Rumble
Ukraine looking to seize assets of UOC’s Family Affairs Department
https://orthochristian.com/180404.html
The Sixth Administrative Court of Appeal opened proceedings on September 22 in the case, which was filed by the state service against the religious organization known as the Synodal Department Mission of the Ukrainian Orthodox Church for Family Affairs. The agency wants the department liquidated and all its property, funds, and other assets—except for liturgical items—transferred to state ownership.
Disgraced Former Harvard President Claudine Gay Rehired to Teach Course on ‘Politics of Race and Immigration’
These studies suggests that blood donated by COVID-19-vaccinated individuals may contain biologically active vaccine-derived constituents that could cause adverse clinical outcomes in recipients.
